Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: results of the EPISTENT trial (Q33825702)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: results of the EPISTENT trial |
scientific article |
Statements
1 reference
Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: results of the EPISTENT trial (English)
1 reference
A M Lincoff
1 reference
1 February 2000
1 reference
1 reference
139
1 reference
2 Pt 2
1 reference
S46-52
1 reference
Identifiers
1 reference
1 reference